Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01322945 · ClinicalTrials.gov registry record
Barrow Nasal Inventory Survey
A clinical trial of Pituitary Tumors, sponsored by St. Joseph's Hospital and Medical Center, Phoenix.
- Completed
- Registry status
- 94
- Enrollment target
- 1
- Study location
NCT01322945: Completed study of Pituitary Tumors, sponsored by St. Joseph's Hospital and Medical Center, Phoenix.
NCT01322945 is a study of Pituitary Tumors that has completed, run by St. Joseph's Hospital and Medical Center, Phoenix. The registered enrollment target is 94 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01322945, a study of Pituitary Tumors, has completed, sponsored by St. Joseph's Hospital and Medical Center, Phoenix.
- COMPLETED
- Registry status
- 94 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate patient nasal outcome following endo-nasal surgery. This type of surgery is conducted for pituitary and skull base tumors. There is no published data on trauma to the nose during surgery and how it impacts nasal functioning. The investigators propose to develop a survey and administer it to patients before and after surgery to learn about their perception of nasal functioning.
Primary Outcome
Mean survey response at 90 days post surgery between the control patients and the endonasal surgery patients using the Anterior skull base nasal inventory (ASK Nasal Inventory. A 5-point Likert scale for each question on the ASK Nasal inventory measures frequency of nasal symptoms where 1=never, 2= a little of the time, 3=some of the time, 4=most of the time, 5= all of the time. Total mean Likert scores were compared in the endonasal group to the control group after surgery. Scores range from mi
Conditions Studied
Study Locations (1)
Arizona
- Barrow Neurological Institute - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2010-10 |
| Est. Completion | 2011-06 |
What the finished NCT01322945 record still lists
NCT01322945 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 94 participants, a relatively small participant target.
The record links to 1 condition, with Pituitary Tumors appearing as the primary indexed condition, and to 0 interventions.
NCT01322945 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT01322945 about?
NCT01322945 is a clinical study titled "Barrow Nasal Inventory Survey". The purpose of this study is to evaluate patient nasal outcome following endo-nasal surgery. This type of surgery is conducted for pituitary and skull base tumors. There is no published data on trauma to the nose during surgery and how it impacts nasal functioning. The investigators propose to devel...
What is the current status of trial NCT01322945?
This trial is currently completed. The enrollment target is 94 participants. The study started on 2010-10. Estimated completion is 2011-06.
What conditions does trial NCT01322945 study?
This clinical trial studies the following conditions: Pituitary Tumors.
Who is sponsoring clinical trial NCT01322945?
This trial is sponsored by St. Joseph's Hospital and Medical Center, Phoenix, which has 44 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01322945 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03747146 · 94 participants · NA
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
- NCT04061421 · 94 participants · Phase 1
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
- NCT04205968 · 94 participants · Phase 2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
- NCT04464759 · 94 participants · Phase 1
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia